These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2274 related items for PubMed ID: 19050033

  • 1. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
    Prescott IA, Dostrovsky JO, Moro E, Hodaie M, Lozano AM, Hutchison WD.
    Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033
    [Abstract] [Full Text] [Related]

  • 2. Lack of depotentiation at basal ganglia output neurons in PD patients with levodopa-induced dyskinesia.
    Prescott IA, Liu LD, Dostrovsky JO, Hodaie M, Lozano AM, Hutchison WD.
    Neurobiol Dis; 2014 Nov; 71():24-33. PubMed ID: 25116960
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias.
    Morgante F, Espay AJ, Gunraj C, Lang AE, Chen R.
    Brain; 2006 Apr; 129(Pt 4):1059-69. PubMed ID: 16476674
    [Abstract] [Full Text] [Related]

  • 10. Effects of deep brain stimulation and medication on bradykinesia and muscle activation in Parkinson's disease.
    Vaillancourt DE, Prodoehl J, Verhagen Metman L, Bakay RA, Corcos DM.
    Brain; 2004 Mar; 127(Pt 3):491-504. PubMed ID: 14662520
    [Abstract] [Full Text] [Related]

  • 11. Beta oscillatory activity in the subthalamic nucleus and its relation to dopaminergic response in Parkinson's disease.
    Weinberger M, Mahant N, Hutchison WD, Lozano AM, Moro E, Hodaie M, Lang AE, Dostrovsky JO.
    J Neurophysiol; 2006 Dec; 96(6):3248-56. PubMed ID: 17005611
    [Abstract] [Full Text] [Related]

  • 12. Subthalamic stimulation and neuronal activity in the substantia nigra in Parkinson's disease.
    Maltête D, Jodoin N, Karachi C, Houeto JL, Navarro S, Cornu P, Agid Y, Welter ML.
    J Neurophysiol; 2007 Jun; 97(6):4017-22. PubMed ID: 17460099
    [Abstract] [Full Text] [Related]

  • 13. Effects of subthalamic nucleus stimulation and medication on resting and postural tremor in Parkinson's disease.
    Sturman MM, Vaillancourt DE, Metman LV, Bakay RA, Corcos DM.
    Brain; 2004 Sep; 127(Pt 9):2131-43. PubMed ID: 15240437
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Myths and realities of continuous dopaminergic stimulation.
    Pirtošek Z.
    Psychiatr Danub; 2011 Mar; 23(1):80-3. PubMed ID: 21448103
    [Abstract] [Full Text] [Related]

  • 18. Modulation of inhibitory plasticity in basal ganglia output nuclei of patients with Parkinson's disease.
    Milosevic L, Gramer R, Kim TH, Algarni M, Fasano A, Kalia SK, Hodaie M, Lozano AM, Popovic MR, Hutchison WD.
    Neurobiol Dis; 2019 Apr; 124():46-56. PubMed ID: 30391540
    [Abstract] [Full Text] [Related]

  • 19. Metabolic, synaptic and behavioral impact of 5-week chronic deep brain stimulation in hemiparkinsonian rats.
    Chassain C, Melon C, Salin P, Vitale F, Couraud S, Durif F, Kerkerian-Le Goff L, Gubellini P.
    J Neurochem; 2016 Mar; 136(5):1004-16. PubMed ID: 26576509
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 114.